Comparison of Low & Conventional Bupivacaine dose On blood Pressure changes in severe Preeclamptic patients

Phase 2

Conditions: severe preeclampsia.
Severe pre-eclampsia

Registration Number: IRCT2016091714056N9

Lead Sponsor: Arak University of Medical Sciences, Vice Chancellor for Research

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 60

Inclusion Criteria

Patients with severe preeclampsia and candidate for caesarian section under spinal anesthesia; ASA I or II; Platelet greater than or equal to 100000; No History of sensitivity to the local anesthetic drug.
Exclusion criteria: Failure in spinal anesthesia; Uncooperative patient in determining the sensory level; Heart failure; Active bleeding; History of renal or hepatic failure; Intracranial hemorrhage or stroke; Neurologic diseases; Psychiatric disorders(Schizophrenia; schizoaffective disorder; schizophreniform disorder; Bipolar disorder); ASA greater than or equal 3

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Systolic blood pressure. Timepoint: before and after spinal anesthesia and every 5 minutes until end of operation. Method of measurement: sphygmomanometer.;Diastolic blood pressure. Timepoint: before and after spinal anesthesia and every 5 minutes until end of operation. Method of measurement: sphygmomanometer.;Mean arterial pressure. Timepoint: before and after spinal anesthesia and every 5 minutes until end of operation. Method of measurement: sphygmomanometer.;Pulse rate. Timepoint: before and after spinal anesthesia and every 5 minutes until end of operation. Method of measurement: pulse rate per minute.;Oxygen saturation. Timepoint: before and after spinal anesthesia and every 5 minutes until end of operation. Method of measurement: Puse oximeter.

Secondary Outcome Measures